Forecasting Hypersensitivity Against PEG-asparaginase to Optimize Outcome in ALL
NCT06195735
·
clinicaltrials.gov ↗
COMPLETED
Status
649
Enrollment
OTHER
Sponsor class
Conditions
Acute Lymphoblastic Leukemia
Sponsor
Aarhus University Hospital
Collaborators
[object Object]
[object Object]